Literature DB >> 31884143

Andrographolide: Chemical modification and its effect on biological activities.

Gulshan Kumar1, Davinder Singh2, Javeed Ahmad Tali2, Divya Dheer2, Ravi Shankar3.   

Abstract

The major natural bioactive constituent of Andrographis paniculata (AP) (Burm. f.) Nees Andrographolide (1) and its derivatives are well acknowledged in literature for its biological activities such as anti-cancer, anti-diabetic, anti-inflammatory, anti-bacterial, anti-malarial, antihepatitis, anti-HIV, anti-atherosclerosis, hepatoprotective, FXR antagonist, and α-glucosidase inhibition. Many reports are available related to Andrographolide (1) but a consolidated review on the chemical modification of andrographolide with special emphasis on its different functional groups with respect to their biological activities is still missing from the previous literature. Therefore, herein we have collected a literature for the period 2009 onwards in relation to chemistry on andrographolide (1) and its effect on respective biological activity. Also, special attempt on increasing the bioavailability of andrographolide (1) has been given for the designing of various targeted drug delivery systems.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acylation; Andrographolide (1); Bioavailability; Biological activities; Chemical modification; Clinical trial; Epoxidation

Year:  2019        PMID: 31884143     DOI: 10.1016/j.bioorg.2019.103511

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  10 in total

1.  Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease.

Authors:  Li-Sha Ran; Ya-Zeng Wu; Yi-Wen Gan; Hong-Lian Wang; Li-Juan Wu; Chun-Mei Zheng; Yao Ming; Ran Xiong; Yong-Lin Li; Shi-Hang Lei; Xue Wang; Xiao-Qing Lao; Hong-Min Zhang; Li Wang; Chen Chen; Chang-Ying Zhao
Journal:  J Nat Med       Date:  2022-09-17       Impact factor: 3.192

2.  Biodistribution of andrographolide to assess the interior-exterior relationship between the lung and intestine using microPET.

Authors:  Qi Zhang; Qingxin Cui
Journal:  Thorac Cancer       Date:  2020-10-05       Impact factor: 3.500

3.  Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  J Ethnopharmacol       Date:  2021-01-21       Impact factor: 5.195

Review 4.  Farnesoid X receptor (FXR): Structures and ligands.

Authors:  Longying Jiang; Huajun Zhang; Desheng Xiao; Hudie Wei; Yongheng Chen
Journal:  Comput Struct Biotechnol J       Date:  2021-04-20       Impact factor: 7.271

5.  Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71.

Authors:  Jie Kai Tan; Ran Chen; Regina Ching Hua Lee; Feng Li; Kun Dai; Guo-Chun Zhou; Justin Jang Hann Chu
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-18

Review 6.  NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics.

Authors:  Na Lu; Weijia Cheng; Dongling Liu; Gang Liu; Can Cui; Chaoli Feng; Xianwei Wang
Journal:  Front Cell Dev Biol       Date:  2022-04-13

7.  Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity.

Authors:  Bianca Schulte; Maria König; Beate I Escher; Sophie Wittenburg; Matic Proj; Valentina Wolf; Carina Lemke; Gregor Schnakenburg; Izidor Sosič; Hendrik Streeck; Christa E Müller; Michael Gütschow; Christian Steinebach
Journal:  ChemMedChem       Date:  2022-01-31       Impact factor: 3.540

8.  Synthesis and Characterization of Andrographolide Derivatives as Regulators of βAPP Processing in Human Cells.

Authors:  Arpita Dey; Ran Chen; Feng Li; Subhamita Maitra; Jean-Francois Hernandez; Guo-Chun Zhou; Bruno Vincent
Journal:  Molecules       Date:  2021-12-17       Impact factor: 4.411

9.  Baicalein Inhibits Metastatic Phenotypes in Nasopharyngeal Carcinoma Cells via a Focal Adhesion Protein Integrin β8.

Authors:  Pichamon Kiatwuthinon; Thana Narkthong; Utapin Ngaokrajang; Supeecha Kumkate; Tavan Janvilisri
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-21

Review 10.  Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Authors:  Jianglian She; Tanwei Gu; Xiaoyan Pang; Yonghong Liu; Lan Tang; Xuefeng Zhou
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.